Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2013 1
2014 3
2015 6
2016 3
2017 4
2018 2
2019 2
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Outcomes and endpoints in trials of cancer treatment: the past, present, and future.
Wilson MK, Karakasis K, Oza AM. Wilson MK, et al. Among authors: karakasis k. Lancet Oncol. 2015 Jan;16(1):e32-42. doi: 10.1016/S1470-2045(14)70375-4. Epub 2014 Dec 29. Lancet Oncol. 2015. PMID: 25638553 Review.
Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma.
Lheureux S, Butler MO, Clarke B, Cristea MC, Martin LP, Tonkin K, Fleming GF, Tinker AV, Hirte HW, Tsoref D, Mackay H, Dhani NC, Ghatage P, Weberpals J, Welch S, Pham NA, Motta V, Sotov V, Wang L, Karakasis K, Udagani S, Kamel-Reid S, Streicher HZ, Shaw P, Oza AM. Lheureux S, et al. Among authors: karakasis k. JAMA Oncol. 2018 Jul 12;4(7):e173776. doi: 10.1001/jamaoncol.2017.3776. Epub 2018 Jul 12. JAMA Oncol. 2018. PMID: 29145543 Free PMC article.
Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization.
Lheureux S, Lai Z, Dougherty BA, Runswick S, Hodgson DR, Timms KM, Lanchbury JS, Kaye S, Gourley C, Bowtell D, Kohn EC, Scott C, Matulonis U, Panzarella T, Karakasis K, Burnier JV, Gilks CB, O'Connor MJ, Robertson JD, Ledermann J, Barrett JC, Ho TW, Oza AM. Lheureux S, et al. Among authors: karakasis k. Clin Cancer Res. 2017 Aug 1;23(15):4086-4094. doi: 10.1158/1078-0432.CCR-16-2615. Epub 2017 Feb 21. Clin Cancer Res. 2017. PMID: 28223274 Free article. Clinical Trial.
Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer.
McMullen M, Karakasis K, Madariaga A, Oza AM. McMullen M, et al. Among authors: karakasis k. Cancers (Basel). 2020 Jun 17;12(6):1607. doi: 10.3390/cancers12061607. Cancers (Basel). 2020. PMID: 32560564 Free PMC article. Review.
Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors.
Yang SYC, Lheureux S, Karakasis K, Burnier JV, Bruce JP, Clouthier DL, Danesh A, Quevedo R, Dowar M, Hanna Y, Li T, Lu L, Xu W, Clarke BA, Ohashi PS, Shaw PA, Pugh TJ, Oza AM. Yang SYC, et al. Among authors: karakasis k. Genome Med. 2018 Oct 31;10(1):81. doi: 10.1186/s13073-018-0590-x. Genome Med. 2018. PMID: 30382883 Free PMC article.
Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer.
Lee YC, Jivraj N, Wang L, Chawla T, Lau J, Croke J, Allard JP, Stuart-McEwan T, Nathwani K, Bowering V, Karakasis K, O'Brien C, Shlomovitz E, Ferguson SE, Buchanan S, Ng P, Cyriac S, Tinker L, Dhani N, Oza AM, Lheureux S. Lee YC, et al. Among authors: karakasis k. J Oncol Pract. 2019 Dec;15(12):e1066-e1075. doi: 10.1200/JOP.18.00793. Epub 2019 Sep 24. J Oncol Pract. 2019. PMID: 31550202
Ovarian cancer treatment: The end of empiricism?
Lheureux S, Karakasis K, Kohn EC, Oza AM. Lheureux S, et al. Among authors: karakasis k. Cancer. 2015 Sep 15;121(18):3203-11. doi: 10.1002/cncr.29481. Epub 2015 Jun 10. Cancer. 2015. PMID: 26096019 Free PMC article. Review.
Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.
Mandilaras V, Vernon M, Meryet-Figuière M, Karakasis K, Lambert B, Poulain L, Oza A, Denoyelle C, Lheureux S. Mandilaras V, et al. Among authors: karakasis k. Expert Opin Biol Ther. 2017 Aug;17(8):927-943. doi: 10.1080/14712598.2017.1340935. Epub 2017 Jun 22. Expert Opin Biol Ther. 2017. PMID: 28641048 Review.
Resisting RECIST-Uniformity Versus Clinical Validity.
Wilson MK, Friedlander ML, Lheureux S, Small W Jr, Poveda A, Pujade-Lauraine E, Karakasis K, Bacon M, Bowering V, Chawla T, Oza AM. Wilson MK, et al. Among authors: karakasis k. Int J Gynecol Cancer. 2017 Oct;27(8):1619-1627. doi: 10.1097/IGC.0000000000001062. Int J Gynecol Cancer. 2017. PMID: 28692635
New Targeted Agents in Endometrial Cancer: Are We Really Making Progress?
Rodriguez-Freixinos V, Karakasis K, Oza AM. Rodriguez-Freixinos V, et al. Among authors: karakasis k. Curr Oncol Rep. 2016 Apr;18(4):23. doi: 10.1007/s11912-016-0507-z. Curr Oncol Rep. 2016. PMID: 26922329 Review.
23 results
Jump to page
Feedback